+Search query
-Structure paper
Title | Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 60, Page 3887-3901, Year 2017 |
Publish date | Feb 1, 2017 (structure data deposition date) |
Authors | Zhao, Y. / Bai, L. / Liu, L. / McEachern, D. / Stuckey, J.A. / Meagher, J.L. / Yang, C.Y. / Ran, X. / Zhou, B. / Hu, Y. ...Zhao, Y. / Bai, L. / Liu, L. / McEachern, D. / Stuckey, J.A. / Meagher, J.L. / Yang, C.Y. / Ran, X. / Zhou, B. / Hu, Y. / Li, X. / Wen, B. / Zhao, T. / Li, S. / Sun, D. / Wang, S. |
External links | J. Med. Chem. / PubMed:28463487 |
Methods | X-ray diffraction |
Resolution | 1.69 Å |
Structure data | PDB-5uoo: |
Chemicals | ChemComp-8FV: ChemComp-HOH: |
Source |
|
Keywords | TRANSCRIPTION / Bromodomain |